Belluscura Plc (BELL) ORD GBP0.01
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Belluscura enters partnership with Sunset HealthCare
13 February 2024 15:16
(Sharecast News) - Belluscura announced a partnership with Sunset HealthCare Solutions, a Chicago-based manufacturer and distributor of home medical equipment, on Tuesday.
-
Belluscura bid for TMT Acquisition goes unconditional
9 February 2024 11:52
(Sharecast News) - Belluscura announced on Friday that the all-share offer for the acquisition of TMT Acquisition had gone unconditional.
-
Belluscura confident in outlook after getting China approval
20 December 2023 14:07
(Sharecast News) - Belluscura has gained approval to distribute its X-PLOR portable oxygen concentrator (POC) in China, it announced on Wednesday, under a licensing agreement with InnoMax Medical Device...
-
Belluscura oxygen concentrator approved in Singapore
12 December 2023 12:10
(Sharecast News) - Belluscura, a medical device developer specialising in portable oxygen enrichment technology, announced approval from the Singapore Health Sciences Authority to distribute its...
-
Belluscura signs 10-year licensing deal in China, Asian markets
30 August 2023 14:16
(Sharecast News) - Medical device developer Belluscura announced a 10-year exclusive licence, marketing and distribution agreement with InnoMax Medical Technology on Wednesday.
-
Belluscura receives 6,500 orders for new oxygen concentrator
16 August 2023 09:50
(Sharecast News) - Medical device developer Belluscura announced on Wednesday that it had received purchase orders for more than 6,500 units of its next-generation 'DISCOV-R' portable oxygen...
-
Belluscura oxygen concentrator launched on GoodRx platform
24 February 2023 14:59
(Sharecast News) - Belluscura announced on Friday that its 'X-PLOR' portable oxygen concentrator (POC) was now available in the US through GoodRx, making it the first medical device in its field...
-
Belluscura makes 'considerable progress' in 2022
13 January 2023 17:12
(Sharecast News) - Portable oxygen concentrator developer Belluscura described "considerable progress" in a trading update on Friday, reporting that since the launch of its first-generation...
-
Belluscura signs manufacturing deal in China
30 March 2022 13:24
(Sharecast News) - Medical device developer Belluscura has signed a manufacturing master supply agreement with InnoMax Medical Technology, it announced on Wednesday, to manufacture the 'X-PLO2R'...
-
Belluscura expectations for oxygen concentrator demand exceeded
4 November 2021 12:32
(Sharecast News) - Oxygen enrichment medical device company Belluscura updated the market on its manufacturing and trading for the year-to-date on Thursday, reporting that demand for its 'X-PLO2R'...
-
Belluscura wins Providers' Choice Gold accolade at Medtrade East in Atlanta
25 October 2021 11:24
(Sharecast News) - Medical device developer Belluscura revealed on Monday that its X-PLO₂R portable oxygen concentrator has won the Providers' Choice Gold accolade at the Medtrade East home medical...
-
Belluscura inks first US distribution agreement
23 June 2021 07:55
(Sharecast News) - Medical device developer Belluscura has signed its first US distribution agreement for the firm's X-PLO2R portable oxygen concentrator portfolio.
Company announcements Announcements
-
Belluscura Concert Party
17 April 2024 07:00
Belluscura
-
Holding(s) in Company
11 April 2024 10:23
Belluscura
-
Holding(s) in Company
8 April 2024 13:15
Belluscura
-
Issue of Equity
5 April 2024 15:48
Belluscura
-
Trading Update
2 April 2024 07:00
Belluscura
-
Total Voting Rights
28 March 2024 07:00
Belluscura
-
Offer Closed
8 March 2024 16:36
Belluscura
-
Cancellation of Listing and trading
7 March 2024 08:30
Belluscura
-
Acceptances level
4 March 2024 07:00
Belluscura
-
Acceptances level
26 February 2024 07:00
Belluscura
-
Acceptances level, issue of equity & AIM Admission
22 February 2024 15:00
Belluscura
-
Acceptances level & offer closing
19 February 2024 07:00
Belluscura
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.